Intelicanna (Israel) Buy Hold or Sell Recommendation
| TEFN Stock | 62.00 0.00 0.00% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Intelicanna is 'Strong Sell'. Macroaxis provides Intelicanna buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding TEFN positions. The advice algorithm takes into account all of Intelicanna's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Intelicanna's buy or sell advice are summarized below:
Real Value 61.57 | Hype Value 62 | Market Value 62 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Intelicanna given historical horizon and risk tolerance towards Intelicanna. When Macroaxis issues a 'buy' or 'sell' recommendation for Intelicanna, the advice is generated through an automated system that utilizes algorithms and statistical models.
Intelicanna |
Execute Intelicanna Buy or Sell Advice
The Intelicanna recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Intelicanna. Macroaxis does not own or have any residual interests in Intelicanna or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Intelicanna's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Intelicanna Trading Alerts and Improvement Suggestions
| Intelicanna generated a negative expected return over the last 90 days | |
| Intelicanna has high historical volatility and very poor performance | |
| Intelicanna has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company has accumulated 1.84 M in total debt with debt to equity ratio (D/E) of 734.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Intelicanna has a current ratio of 0.28, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Intelicanna until it has trouble settling it off, either with new capital or with free cash flow. So, Intelicanna's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Intelicanna sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Intelicanna to invest in growth at high rates of return. When we think about Intelicanna's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 40.44 M. Net Loss for the year was (24.63 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Intelicanna has accumulated about 1.04 M in cash with (10.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11. |
Intelicanna Returns Distribution Density
The distribution of Intelicanna's historical returns is an attempt to chart the uncertainty of Intelicanna's future price movements. The chart of the probability distribution of Intelicanna daily returns describes the distribution of returns around its average expected value. We use Intelicanna price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Intelicanna returns is essential to provide solid investment advice for Intelicanna.
| Mean Return | -0.65 | Value At Risk | -8.72 | Potential Upside | 6.04 | Standard Deviation | 5.51 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Intelicanna historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Intelicanna Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Intelicanna or Professional Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Intelicanna's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Intelicanna stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.58 | |
β | Beta against NYSE Composite | -0.96 | |
σ | Overall volatility | 4.29 | |
Ir | Information ratio | -0.13 |
Intelicanna Volatility Alert
Intelicanna exhibits very low volatility with skewness of 1.31 and kurtosis of 6.53. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Intelicanna's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Intelicanna's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Intelicanna Fundamentals Vs Peers
Comparing Intelicanna's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Intelicanna's direct or indirect competition across all of the common fundamentals between Intelicanna and the related equities. This way, we can detect undervalued stocks with similar characteristics as Intelicanna or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Intelicanna's fundamental indicators could also be used in its relative valuation, which is a method of valuing Intelicanna by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Intelicanna to competition |
| Fundamentals | Intelicanna | Peer Average |
| Price To Earning | (327.15) X | 28.72 X |
| Revenue | 40.44 M | 9.43 B |
| EBITDA | 2.29 M | 3.9 B |
| Net Income | (24.63 M) | 570.98 M |
| Cash And Equivalents | 1.04 M | 2.7 B |
| Cash Per Share | 0.11 X | 5.01 X |
| Total Debt | 1.84 M | 5.32 B |
| Debt To Equity | 734.90 % | 48.70 % |
| Current Ratio | 0.29 X | 2.16 X |
| Book Value Per Share | (1.83) X | 1.93 K |
| Cash Flow From Operations | (10.15 M) | 971.22 M |
| Earnings Per Share | (4.74) X | 3.12 X |
| Number Of Employees | 22 | 18.84 K |
| Beta | -1.79 | -0.15 |
| Market Capitalization | 374.13 M | 19.03 B |
| Total Asset | 48.3 M | 29.47 B |
| Retained Earnings | 4 M | 9.33 B |
| Current Asset | 22 M | 9.34 B |
| Current Liabilities | 22 M | 7.9 B |
| Net Asset | 48.3 M |
Intelicanna Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Intelicanna . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Intelicanna Buy or Sell Advice
When is the right time to buy or sell Intelicanna? Buying financial instruments such as Intelicanna Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Intelicanna in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cancer Fighters Thematic Idea Now
Cancer Fighters
Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. The Cancer Fighters theme has 59 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cancer Fighters Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Intelicanna Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Intelicanna Stock analysis
When running Intelicanna's price analysis, check to measure Intelicanna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelicanna is operating at the current time. Most of Intelicanna's value examination focuses on studying past and present price action to predict the probability of Intelicanna's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelicanna's price. Additionally, you may evaluate how the addition of Intelicanna to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |